Brief: Glaxosmithkline Pharma Q4 Consol Profit 2.63 Billion Rupees
13/05/2025 11:29
May 13 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd GLAX.NS: Q4 CONSOL PROFIT 2.63 BILLION RUPEES BOARD RECOMMENDS FINAL DIVIDEND OF 42 RUPEES PER SHARE Q4 CONSOL REVENUE FROM OPERATIONS 9.74 BILLION RUPEES Source text: ID:nBSEbqJ4kt Further company coverage: GLAX.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees